• Tesco's shrinking market share eases as scandal drags Tuesday, 21 Oct 2014 | 5:49 AM ET
    A customer carries Tesco-branded shopping bags as she leaves one of the company's stores.

    The market share of U.K. supermarket Tesco continues to shrink, but data shows the retailer may have turned a corner as the slide eases.

  • The $1,000 pill that could cripple the VA’s budget Wednesday, 8 Oct 2014 | 10:33 AM ET

    The Department of Veterans Affairs, has a new problem on its hands: a $1000 pill, The Fiscal Times reports.

  • GSK investigating corruption allegations in UAE Wednesday, 8 Oct 2014 | 1:17 AM ET

    GlaxoSmithKline, which was slapped with a record fine for corruption in China, said it was looking into allegations of corruption in UAE.

  • Chimerix: New experimental Ebola drug has potential Monday, 6 Oct 2014 | 1:52 PM ET

    Chimerix said its experimental Ebola drug has been provided for potential use in patients, sending its shares sharply higher in premarket trading.

  • Roche breast cancer drug results 'unprecedented' Monday, 29 Sep 2014 | 6:46 AM ET
    Woman having a mammography scan.

    A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial.

  • Vivus shares rally on erectile dysfunction drug nod Thursday, 18 Sep 2014 | 8:14 AM ET

    An erectile dysfunction drug that reduces by half the time patients need to take the pill has been approved by the U.S. Food and Drug Administration.

  • Cops: Man tried to sell Pop-Tarts...as cocaine Monday, 15 Sep 2014 | 12:09 PM ET

    An N.C. man faces charges after being arrested on suspicion of selling crushed Pop-Tarts—as crack cocaine, a TV station reports.

  • Sept 4- Drug developer Recro Pharma Inc said it planned to end a mid-stage trial of its lead post-operative pain drug because it did not expect the trial to achieve statistically significant results under its current design. The company's shares fell as much as 20 percent in extended trading.

  • Aug 27- Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.

  • FedEx indicted on new criminal charges Friday, 15 Aug 2014 | 2:45 PM ET

    FedEx was indicted in a U.S. criminal case for conspiracy to launder money over deliveries for illegal online pharmacies.

  • Aug 15- Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment. The FDA in May said data was insufficient to support the company's claim that the drug could not be abused by snorting.

  • FDA enables potential use of Tekmira's Ebola drug Thursday, 7 Aug 2014 | 4:59 PM ET

    The move enables the potential use of TKM-Ebola in individuals infected with Ebola virus.

  • The out-of-control country no one's talking about Thursday, 7 Aug 2014 | 8:51 AM ET
    A street market in Cidade del Este, Paraguay, is shown in this photo.

    Piracy, possible Hezbollah funding, drugs and human trafficking indicate that we should pay attention to Paraguay. Global Post reports.

  • Will generic Viagra transform China? Tuesday, 5 Aug 2014 | 6:21 PM ET

    Viagra's patent in China has expired and some analysts expect cheaper prices will bring a surge of demand for the storied erectile dysfunction drug.

  • Feds charge Biogenesis owner Bosch in steroids case Tuesday, 5 Aug 2014 | 11:23 AM ET
    In this booking photo provided by the Miami-Dade Police Department, Anthony Bosch poses for his mug shot April 4, 2012 in Key Biscayne, Florida. Bosch, founder of the Biogenesis anti-aging clinic, was arrested for driving with a suspended license.

    Biogenesis founder Anthony Bosch self-surrendered to authorities, a spokesperson for the U.S. Drug Enforcement Administration said.

  • Ebola serum arrives in Liberia, only enough for one Thursday, 31 Jul 2014 | 2:19 PM ET
    A pharmacist searches for drugs in a pharmacy in Lagos, Nigeria, July 26, 2014.

    A dose of experimental serum arrived in Liberia to be tried on a U.S. charity worker—but there was only enough for one of the two infected workers, NBC.

  • FedEx pleads not guilty to online pharmacy charges Tuesday, 29 Jul 2014 | 4:07 PM ET

    FedEx said it would fight any additional charges if they are brought. FedEx is due back in court Sept. 24 in San Francisco for a status conference.

  • FedEx hires Barry Bonds lawyers for drug case Tuesday, 29 Jul 2014 | 9:32 AM ET
    Former Major League Baseball player Barry Bonds (C) stands with his attorneys, Allen Ruby and Cristina Arguedas, they leave San Francisco federal court in a file photo from April 13, 2011.

    FedEx hired attorneys who represented Barry Bonds to defend against charges that it knowingly shipped packages from illegal pharmacies.

  • European shares tip lower on U.S. data, Russia risk Monday, 28 Jul 2014 | 12:33 PM ET

    *FTSEurofirst 300 down 0.2 pct, Euro STOXX 50 down 0.1 pct. *Ryanair, Reckitt outperform on earnings, dealmaking. LONDON/ PARIS, July 28- European stocks edged lower on Monday, with unspectacular U.S. data and new European sanctions against Moscow offsetting strong earnings updates from firms like Ryanair and spin-off talk from Reckitt Benckiser.

  • European shares subdued as investors weigh earnings Monday, 28 Jul 2014 | 7:20 AM ET

    *FTSEurofirst 300 flat, Euro STOXX 50 up 0.1 pct. *Ryanair, Reckitt outperform on earnings, dealmaking. LONDON/ PARIS, July 28- European stocks traded flat on Monday, with strong earnings updates from firms like Ryanair and spin-off talk from Reckitt Benckiser balancing concerns over the implications of new international sanctions on Russia.